Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus

World Journal of Gastroenterology

Volumn 20, Issue 28, 2014, Pages 9611-9617

  Gatenby, Piers ^a   Caygill, Christine ^a   Wall, Christine ^a   Bhatacharjee, Santanu ^a   Ramus, James ^a   Watson, Anthony ^a   Winslet, Marc ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Barrett esophagus; Cohort studies; Esophageal neoplasms; Forecasting; Meta analysis

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; FEMALE; HUMAN; INTESTINE METAPLASIA; LIFE EXPECTANCY; LIFESPAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PATIENT RISK; RISK ASSESSMENT; RISK FACTOR; ADENOCARCINOMA; AGE; ESOPHAGEAL NEOPLASMS; INCIDENCE; META ANALYSIS; MIDDLE AGED; PRECANCEROUS CONDITIONS; REGISTER; SEX DIFFERENCE; STATISTICAL MODEL; TIME; UNITED KINGDOM; VERY ELDERLY;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LIFE EXPECTANCY; LINEAR MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; PRECANCEROUS CONDITIONS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 84908896658     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i28.9611     Document Type: Article

References (30)

1. Watson A, Heading R, Shepherd N. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus: A Report of the Working Party of the British Society of Gastroenterology. Available from: URL: http://www.bsg.org.uk/clinical-guidelines/general/guidelines-by-date.html
2. Rosztóczy A, Izbéki F, Róka R, Németh I, Gecse K, Vadászi K, Kádár J, Vetró E, Tiszlavicz L, Wittmann T. The evaluation of oesophageal function in patients with different types of oesophageal metaplasia. Digestion 2011; 84: 273-280 [PMID: 21997472 DOI: 10.1159/000330823]
3. Gatenby PA, Caygill CP, Ramus JR, Charlett A, Watson A. Barrett's columnar-lined oesophagus: demographic and lifestyle associations and adenocarcinoma risk. Dig Dis Sci 2008; 53: 1175-1185 [PMID: 17939050]
4. Gatenby P, Ramus J, Caygill C, Shepherd N, Winslet M, Watson A. Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: a population-based study of natural history. Histopathology 2009; 54: 814-819 [PMID: 19635100 DOI: 10.1111/j.1365-2559.2009.03316.x]
5. Desai TK, Krishnan K, Samala N, Singh J, Cluley J, Perla S, Howden CW. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut 2012; 61: 970-976 [PMID: 21997553 DOI: 10.1136/gutjnl-2011-300730]
6. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and highgrade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008; 168: 237-249 [PMID: 18550563 DOI: 10.1093/aje/kwn121]
7. Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010; 8: 235-44; quiz e32 [PMID: 19850156 DOI: 10.1016/j.cgh.2009.10.010]
8. Thomas T, Abrams KR, De Caestecker JS, Robinson RJ. Meta analysis: Cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther 2007; 26: 1465-1477 [PMID: 17900269]
9. Watson A. Barrett's oesophagus-50 years on. Br J Surg 2000; 87: 529-531 [PMID: 10792304]
10. Gatenby PA, Ramus JR, Caygill CP, Fitzgerald RC, Charlett A, Winslet MC, Watson A. The influence of symptom type and duration on the fate of the metaplastic columnar-lined Barrett's oesophagus. Aliment Pharmacol Ther 2009; 29: 1096-1105 [PMID: 19222408 DOI: 10.1111/j.1365-2036.2009.03969.x]
11. Caygill CP, Royston C, Charlett A, Wall CM, Gatenby PA, Ramus JR, Watson A, Winslet M, Bardhan KD. Mortality in Barrett's esophagus: three decades of experience at a single center. Endoscopy 2012; 44: 892-898 [PMID: 22752886 DOI: 10.1055/s-0032-1309842]
12. Office for National Statistics. Cancer survival in England: one-year and five-year survival for 21 common cancers, by sex and age. Available from: URL: http://www.ons.gov.uk/ons/taxonomy/index.html?nscl=Cancer Survival
13. Office for National Statistics. Death Registrations Summary Tables, England and Wales, 2012. Available from: URL: http://www.ons.gov.uk/ons/rel/vsob1/death-reg-sumtables/2012/index.html
14. Caygill CP, Reed PI, Watson A, Hill MJ. The UK National Barrett's Oesophagus Registry (UKBOR): aims and progress. Eur J Cancer Prev 2001; 10: 97-99 [PMID: 11263598]
15. Kelty CJ, Gough MD, Van Wyk Q, Stephenson TJ, Ackroyd R. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol 2007; 42: 1271-1274 [PMID: 17852872]
16. Gatenby PA, Ramus JR, Caygill CP, Shepherd NA, Watson A. Relevance of the detection of intestinal metaplasia in nondysplastic columnar-lined oesophagus. Scand J Gastroenterol 2008; 43: 524-530 [PMID: 18415743 DOI: 10.1080/0036552070 1879831]
17. Office of National Statistics. 2008-based period and cohort life expectancy tables. Available from: URL: http://www.ons.gov.uk/ons/rel/lifetables/period-and-cohort-lifeexpectancy-tables/2008-based/index.html
18. Gatenby PA, Caygill CP, Ramus JR, Charlett A, Fitzgerald RC, Watson A. Short segment columnar-lined oesophagus: an underestimated cancer risk? A large cohort study of the relationship between Barrett's columnar-lined oesophagus segment length and adenocarcinoma risk. Eur J Gastroenterol Hepatol 2007; 19: 969-975 [PMID: 18049166]
19. Westerhoff M, Hovan L, Lee C, Hart J. Effects of dropping the requirement for goblet cells from the diagnosis of Barrett's esophagus. Clin Gastroenterol Hepatol 2012; 10: 1232-1236 [PMID: 22642957 DOI: 10.1016/j.cgh.2012.05.013]
20. Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, Murray LJ. Risk of malignant progression in Barrett's esophagus patients: results from a large populationbased study. J Natl Cancer Inst 2011; 103: 1049-1057 [PMID: 21680910 DOI: 10.1093/jnci/djr203]
21. Anderson LA, Watson RG, Murphy SJ, Johnston BT, Comber H, Mc Guigan J, Reynolds JV, Murray LJ. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 2007; 13: 1585-1594 [PMID: 17461453]
22. Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, Kleibeuker JH. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut 1999; 45: 489-494 [PMID: 10486353]
23. El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 2004; 99: 1877-1883 [PMID: 15447744]
24. Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust 2004; 180: 387-391 [PMID: 15089728]
25. Wall CM, Charlett A, Caygill CP, Gatenby PA, Ramus JR, Winslet MC, Watson A. Are newly diagnosed columnarlined oesophagus patients getting younger? Eur J Gastroenterol Hepatol 2009; 21: 1127-1131 [PMID: 19295439 DOI: 10.1097/MEG.0b013e328329c414]
26. Solaymani-Dodaran M, Card TR, West J. Cause-specific mortality of people with Barrett's esophagus compared with the general population: a population-based cohort study. Gastroenterology 2013; 144: 1375-183, 1383.e1 [PMID: 23583429 DOI: 10.1053/j.gastro.2013.02.050]
27. de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut 2010; 59: 1030-1036 [PMID: 20639249 DOI: 10.1136/gut.2009.176701]
28. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-1383 [PMID: 21995385 DOI: 10.1056/NEJMoa1103042]
29. Office for National Statistics. Cancer Statistics Registrations, England Series MB1, No.42, 2011. Available from: URL: http://www.ons.gov.uk/ons/rel/vsob1/cancer-statisticsregistrations-england-series-mb1-/no-42-2011/index.html
30. Gatenby PA, Hainsworth A, Caygill C, Watson A, Winslet M. Projections for oesophageal cancer incidence in England to 2033. Eur J Cancer Prev 2011; 20: 283-286 [PMID: 21422931 DOI: 10.1097/CEJ.0b013e32834572d2]